Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  chlorambucil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 88 for your search:
Start Over
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22468, 2009-012072-28, NCT01056510
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25137, NCT01283386
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000068650, EORTC-06992-CLL-3, NCT00017108
Phase III Study of Surgery and Chemotherapy with L-PAM or 5-FU/MTX/VCR/CTX/PRED for Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7436
Limited Phase III Chemotherapy with ADR plus Chlorambucil or Thiabendazole for Bronchogenic Carcinoma (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7766
Phase III Chemotherapy with 5-FU/CTX, ADR/VCR/PRED, MTX/VCR/PRED, 5-FU/CTX/PRED/VCR/MTX and Therapy with Calusterone for Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-7550
Phase III Chemotherapy with Chlorambucil for Indolent Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7632
Phase III Study of Induction with Chlorambucil and Secondary Therapy with VBL/MTX/CTX/PRED for Histiocytosis X in Children
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15
Sponsor: NCI
Protocol IDs: CCG-941
Phase III CLB/PRED vs CVP (CTX/VCR/PRED) for Active Stage II/III/IV Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2480
Phase III CAFTH (CTX/ADR/5-FU/TMX/HAL) Alone or Followed by Radiotherapy for Resected, Locally Advanced Male and Female Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3181
Phase III Study of Radiotherapy and Chemotherapy with VCR/PCB/BCNU/PRED and CLB for Stage III Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 65
Sponsor: NCI
Protocol IDs: CLB-7451
Phase III Randomized Comparison of Intermittent CLB/PRED vs CLB/PRED plus Low-Dose TBI for Stage III/IV NHL with Favorable Characteristics
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-NHL-81344
Phase III CLB/PRED Chemotherapy with vs without Total Body Irradiation for Previously Untreated Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-79CLL348
Phase III Prospective Study of Treatment of Hairy Cell Leukemia with Sequential Splenectomy, CLB, and Leukapheresis
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2843, ICC-78H1, NCI-V83-0137
Phase III Study of Various Combinations of Radiotherapy, COMLA, COPA, COPP, BACOP, and CLB/PRED Based on Stage and Initial Response for non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2121A, NCI-V83-0123
Phase III Treatment of Newly Diagnosed and Recurrent non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCCRC-3953, NCI-V84-0037
Start Over